In contrast to its production by adipocytes in mice, human resistin is expressed predominantly in leukocytes (12–14), and has always been considered as a pro-inflammatory molecule that plays a regulatory role in many human chronic inflammatory diseases (15), metabolic diseases (16), infectious diseases (17–19), and cancers (20). The gene discussed is RETN; the disease is metabolic disease.